About
Pharos builds an AI-powered hospital quality-reporting and patient-safety analytics platform for hospital quality and risk teams. Its software automates chart abstraction and data extraction from medical records, supports clinical-registry reporting, and surfaces process failures contributing to avoidable harm. Its differentiation is real-time, verifiable clinical metrics that reduce manual review and help hospitals act before patient harm occurs.
Market
Pharos competes in the healthcare AI market for hospital quality reporting, clinical-registry abstraction, and patient-safety and risk analytics. It positions itself as an AI-native workflow that extracts required data from unstructured medical records, automates reporting, and helps teams identify process failures and avoidable harm. Its stated differentiation is combining chart-abstraction automation with quality monitoring, analytics, and root-cause analysis rather than offering reporting or abstraction alone.
Pharos primarily serves hospitals and hospital quality organizations that need to abstract patient-chart data for clinical registries and automate quality reporting. Its main users and likely buyers are quality, risk, patient-safety, and clinical-operations teams; the available evidence does not specify a preferred hospital size.
At a Glance
Problem
Hospitals need to identify avoidable harm, understand its causes, report quality metrics to clinical registries, and demonstrate performance under quality-improvement and value-based-care programs. Yet quality teams and clinicians must manually sift through unstructured electronic medical records to find risk factors, process failures, and evidence of care quality. A single complex case can take up to eight hours of clinical time; one hospital may spend as much as $5 million annually on extraction, while the resulting data arrives weeks after discharge and covers only a small sample of patients.
The killer use case is turning every patient journey into actionable quality data quickly enough to prevent harm rather than merely document it. That includes finding process failures associated with sepsis, hospital-acquired infections, pressure ulcers, and other adverse events, while reducing the labor burden of mandatory or strategically important reporting to organizations such as CMS and the American College of Surgeons.
Product / Service
Pharos is a hospital-facing, AI-powered analytics platform for quality and risk teams. Its AI reads patient charts and automatically extracts the structured facts required for clinical-registry submissions and other quality analyses, producing verifiable metrics linked back to the source medical record. The company positions the product as a way to automate reporting for registries and value-based reimbursement contracts while avoiding additional IT-backlog and clinical-reviewer workload.
Beyond abstraction, Pharos provides rapid hospital reporting, root-cause analyses, audits against Joint Commission and CMS metrics, and monitoring of quality-improvement projects. It is designed to let clinicians complete RCAs in hours instead of weeks, detect near misses, understand the causes of safety events, and measure whether interventions are working in near real time. Public materials describe a demo-led software offering but do not disclose pricing or implementation details.
Market
Pharos competes in the narrower market for AI-enabled clinical data abstraction, hospital quality reporting, patient-safety analytics, and risk-management software. Its customers are hospital and health-system quality, safety, and risk teams. In October 2024, TechCrunch described the quality-reporting niche as one in which no other startups were then pursuing the problem directly, suggesting that Pharos entered with a differentiated position against the incumbent alternative of manual in-house abstraction. Adjacent alternatives include Health Catalyst’s technology-enabled clinical chart-abstraction tools and broader patient-safety and risk platforms, but the available evidence does not establish that these are direct like-for-like competitors.
Pharos has clear financing and ecosystem traction: it was founded in 2024, participated in Y Combinator’s Summer 2024 cohort, and raised a $5 million seed round led by Felicis with participation from General Catalyst, Moxxie, and Y Combinator. Its public site also highlights 2025 work on abstraction performance and engagement with CMS. However, the reviewed materials do not disclose revenue, paying-customer counts, hospital deployment numbers, or a definitive pre-revenue status; the best-supported characterization is an early commercial-stage company with funding and product-validation signals but undisclosed sales traction.
Founders & Leadership
Funding History
Moxxie Ventures, Y Combinator
Felicis
Recent News
A medRxiv preprint by Pharos Health researchers evaluates a neuro-symbolic AI system for abstracting four pathology quality measures from 2,000 reports. The study reports agreement with adjudicated gold standards that exceeded trained human abstractors’ inter-rater reliability; Pharos developed and funded the evaluated system.
The Council of Medical Specialty Societies’ 2025 Industry Partner Resource eBook lists Pharos as an industry partner. It describes Pharos’s AI for automating hospital quality reporting, registry abstraction, process-adherence measures, and patient-safety indicators.
Pharos reported presenting results at the 2025 Council of Medical Specialty Societies meeting that demonstrated human-level abstraction performance on highly messy medical data.
Active Roles
3Business Model
Pharos monetizes as a business-to-business healthcare SaaS company, selling its AI-powered analytics and reporting platform to hospitals and health systems, particularly quality and risk-management teams. Public sources identify the product as SaaS but do not disclose exact subscription pricing or contract terms.